Ratings by StoneX (Aydin Huseynov)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2023 | Processa Pharmaceuticals | PCSA | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 12/10/2021 | Spruce Biosciences, Inc. | SPRB | New Coverage | Speculative Buy (N/A) |
2.56 (54.35) |
2023.05% | Details | |
| 11/17/2021 | Trillium Therapeutics | TRIL | Downgrade | Hold (Buy) |
18.44 (19.86) |
7.7% | Details | |
| 11/8/2021 | Nektar Therapeutics | NKTR | Upgrade | Buy (Hold) |
13.45 (70.65) |
425.28% | Details | |
| 11/5/2021 | Regeneron Pharma | REGN | Downgrade | Hold (Buy) |
647.63 (793.26) |
22.49% | Details | |
| 10/1/2021 | Compass Therapeutics | CMPX | New Coverage | Speculative Buy (N/A) |
3.41 (2.05) |
-39.88% | Details | |
| 7/20/2021 | Incyte | INCY | Upgrade | Buy (Neutral) |
77.56 (123.28) |
58.95% | Details | |
| 2/22/2021 | Nektar Therapeutics | NKTR | Downgrade | Hold (Buy) |
24.92 (70.65) |
183.51% | Details | |
| 2/16/2021 | Scopus Biopharma | SCPS | New Coverage | Speculative Buy (N/A) |
10.30 (0.00) |
-100% | Details | |
| 1/13/2021 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
502.92 (793.26) |
57.73% | Details | |
| 12/8/2020 | Processa Pharmaceuticals | PCSA | New Coverage | Buy (N/A) |
7.50 (1.85) |
-75.33% | Details | |
| 9/2/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Hold (N/A) |
54.27 (55.65) |
2.54% | Details | |
| 8/20/2020 | Regeneron Pharma | REGN | Downgrade | Hold (Buy) |
629.63 (793.26) |
25.99% | Details | |
| 7/16/2020 | NextCure Inc. | NXTC | Upgrade | Buy (Hold) |
9.01 (7.31) |
-18.87% | Details | |
| 6/25/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2020 | Salarius Pharmaceuticals | SLRX | New Coverage | Speculative Buy (N/A) |
1.77 (0.84) |
-52.54% | Details | |
| 6/16/2020 | Incyte | INCY | New Coverage | Hold (N/A) |
93.51 (123.28) |
31.84% | Details | |
| 6/1/2020 | NextCure Inc. | NXTC | Downgrade | Hold (Buy) |
31.21 (7.31) |
-76.58% | Details | |
| 5/21/2020 | Inovio Pharmaceuticals | INO | New Coverage | Buy (N/A) |
15.79 (1.28) |
-91.89% | Details | |
| 4/17/2020 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
539.93 (793.26) |
46.92% | Details | |
| 4/8/2020 | Regeneron Pharma | REGN | New Coverage | Hold (N/A) |
501.51 (793.26) |
58.17% | Details | |
| 3/24/2020 | NextCure Inc. | NXTC | New Coverage | Buy (N/A) |
32.32 (7.31) |
-77.38% | Details | |
| 3/19/2020 | Voyager Therapeutics | VYGR | New Coverage | Buy (N/A) |
7.16 (3.19) |
-55.45% | Details |
